Two oncology powerhouses are integrating to accelerate cancer vaccine research

“Our strategy is not just funding potential game-changing science, although we do do that,” Knudsen said. “It’s to pull it all the way through, from bench to bedside to marketplace, right in one ecosystem. We take those ideas, and we provide the capital and the structure and the project management and the regulatory support to ensure that they get the best possible test in humans as quickly as possible.”

MM + M - April 21, 2026